118 related articles for article (PubMed ID: 603758)
1. Comparison of heparin and a semi-synthetic heparin analogue, A73025. II. Some effects on platelet function.
Michalski R; Lane DA; Kakkar VV
Br J Haematol; 1977 Oct; 37(2):247-56. PubMed ID: 603758
[TBL] [Abstract][Full Text] [Related]
2. Comparison of heparin and a semi-synthetic heparin analogue, A73025. I. Kinetics of clearance from the circulation of man following intravenous injection.
Lane DA; Michalski R; Van Ross ME; Kakkar VV
Br J Haematol; 1977 Oct; 37(2):239-45. PubMed ID: 603757
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-molecular-weight heparin on platelets as compared with commercial heparin.
Cella G; Scattolo N; Luzzatto G; Girolami A
Res Exp Med (Berl); 1984; 184(4):227-9. PubMed ID: 6494594
[TBL] [Abstract][Full Text] [Related]
4. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
5. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
[TBL] [Abstract][Full Text] [Related]
7. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
[TBL] [Abstract][Full Text] [Related]
8. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
Vinazzer H; Woler M
Thromb Res; 1985 Oct; 40(2):135-46. PubMed ID: 3878009
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro.
Westwick J; Scully MF; Poll C; Kakkar VV
Thromb Res; 1986 May; 42(4):435-47. PubMed ID: 3715810
[TBL] [Abstract][Full Text] [Related]
11. [Effect of heparin on the aggregation function of thrombocytes].
Zhukovskaia ES; Blindar' VN
Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
[TBL] [Abstract][Full Text] [Related]
12. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.
Boyd DG; Davis RB
Thromb Res; 1988 May; 50(3):429-36. PubMed ID: 3394122
[TBL] [Abstract][Full Text] [Related]
13. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
Han P; Ardlie NG
Br J Haematol; 1974 Jun; 27(2):253-72. PubMed ID: 4843673
[No Abstract] [Full Text] [Related]
14. Effects of heparin and alpha 1-acid glycoprotein on thrombin or Activated Thrombofax Reagent-induced platelet aggregation and clot formation.
Fiedel BA; Costello M; Gewurz H; Hussissian E
Haemostasis; 1983; 13(2):89-95. PubMed ID: 6873753
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
16. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
Cofrancesco E; Colombi M; Gianese F; Cortellaro M
Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
[TBL] [Abstract][Full Text] [Related]
17. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro.
Haaland HD; Holmsen H
Platelets; 2011; 22(5):328-37. PubMed ID: 21388249
[TBL] [Abstract][Full Text] [Related]
18. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
[TBL] [Abstract][Full Text] [Related]
19. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
Lages B; Weiss HJ
Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
[TBL] [Abstract][Full Text] [Related]
20. Normal and low molecular weight heparins: interaction with human platelets.
Fabris F; Fussi F; Casonato A; Visentin L; Randi M; Smith MR; Girolami A
Eur J Clin Invest; 1983 Apr; 13(2):135-9. PubMed ID: 6223824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]